What question the book answers
When someone pitches you a peptide, how do you sort the claim? The book teaches two labels and two questions. The labels are an evidence tier (how much human proof sits under a specific claim) and a regulatory bucket (what the law says about the product). The questions are: What tier is the evidence? Who profits if you say yes?
What it deliberately does not promise
It does not tell you what to take, how much, how often, or where to buy anything. It does not recommend a product or a seller. It is educational only. Dr. Michael Peters is a retired physician and does not practice medicine.
Chapter-to-resource map
The book has five parts. Each connects to a live resource where one exists.
- Part I, the basics: what a peptide is, and how it differs from a protein, a hormone, and a drug.
- Part II, the compounds people ask about, by question rather than by molecule: the peptide status directory.
- Part III, midlife: how peptides differ from hormone therapy, and the things that still outperform them.
- Part IV, stacks, prescriptions, and how to spot a bad pitch: the evidence review's questions for a clinician.
- Part V, how to decide: a one-page scorecard to complete for any claim.
Key terms and evidence tiers
Evidence tiers are A, B, C, and Preclinical. Regulatory buckets are Approved, Compoundable, Under review, and Research-only. They are separate: a compound can be fully approved and have no evidence for the use being pitched to you.
What has changed since publication
The book is not yet published. Regulatory status changes quickly; the status directory carries an as-of date and is the living layer.
Related
Educational information only, not medical advice, diagnosis, or treatment. Dr. Michael Peters is a retired physician and does not practice medicine. This page offers no personalized interpretation.